On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

XPA

XPA, DNA damage recognition and repair factor

Chromosome 9q22.33 Autosomal recessive HGNC:12814 Tier C
XPA 9q22.33 p arm q arm 9

XPA is located on the long (q) arm of chromosome 9, at band 9q22.33. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 9 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The XPA gene provides instructions for producing a protein that plays a central role in detecting and repairing damaged DNA. DNA sustains damage constantly from ultraviolet radiation, environmental chemicals, and metabolic by-products. Without effective repair mechanisms, this damage accumulates and can lead to cell death or malignant transformation.

The XPA protein functions as a damage verification factor within the nucleotide excision repair pathway, one of the cell's primary defences against bulky DNA lesions. Pathogenic variants in XPA cause xeroderma pigmentosum, an autosomal recessive disorder characterised by extreme photosensitivity and dramatically elevated skin cancer risk. The gene is located at chromosome 9q22.33 and encodes a 273-amino acid protein.

What the gene does

XPA protein serves as a damage-recognition and scaffolding factor during nucleotide excision repair. When DNA sustains damage from UV light or chemical mutagens, XPA binds to the affected sites and stabilises the repair complex whilst other proteins excise and replace the damaged segment. The protein interacts with multiple repair factors simultaneously, coordinating their assembly at lesion sites.

The protein's zinc finger domain enables it to bind damaged DNA with specificity, distinguishing distorted helical structures from normal double-stranded DNA. Following damage verification, XPA remains bound throughout the repair process, providing structural support whilst endonucleases remove the damaged strand and polymerases synthesise replacement DNA. This verification function prevents inappropriate excision of undamaged DNA and ensures repair machinery targets genuine lesions. The protein's interaction with CEP164 in the N-terminal region contributes to UV resistance, though the precise mechanism linking centrosomal protein recruitment to DNA repair remains an active research question.

Video: Genetics 101

Chromosome location

XPA is located on the long arm of chromosome 9 at position 22.33 (9q22.33). This chromosomal region contains several genes involved in cellular stress responses and genomic stability maintenance. The gene structure and regulatory elements coordinate XPA expression with other nucleotide excision repair components, ensuring balanced production of repair machinery proteins.

Protein structure

The XPA protein comprises 273 amino acids organised into functionally distinct regions. The N-terminal region spanning amino acids 4-97 mediates interaction with CEP164 and is required for UV resistance. Within this region, a nuclear localisation signal extends from amino acids 26-47, directing the protein to the nucleus where DNA repair occurs. The central zinc finger domain, located at amino acids 105-129, coordinates zinc ions to form a structure that recognises and binds damaged DNA, providing specificity for distorted helical conformations characteristic of bulky lesions.

Domain map · 273 amino acids
Interaction with CEP164 and required for UV resistance (4-97)Nuclear localization signal (26-47)Zinc finger (105-129)Interaction with CEP164-97Nuclear localization s26-47Zinc finger105-1291~137273
Region - functional region
Motif - short conserved sequence
Zinc finger - zinc-binding structural motif
🧬 Explore 3D structure on AlphaFold
UniProt:P23025Length:273 aaStructure:AlphaFold

Key variants

Pathogenic variants throughout the XPA gene disrupt DNA repair capacity, though the severity of functional impairment varies with the specific change and its effect on protein stability or DNA-binding ability. Loss-of-function variants that eliminate protein production typically cause severe presentations, whilst some missense changes may retain partial activity. Japanese populations show higher carrier frequencies for certain XPA variants compared to other ancestries.

No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.

Associated conditions

Pathogenic variants in XPA cause xeroderma pigmentosum, an autosomal recessive condition characterised by extreme sensitivity to ultraviolet radiation. Affected individuals develop severe sunburn after minimal sun exposure and face substantially elevated risk of skin cancers, often appearing in childhood. XPA-related xeroderma pigmentosum represents one of the more severe forms of this heterogeneous disorder, frequently accompanied by progressive neurological deterioration in addition to the cutaneous manifestations.

  • Xeroderma pigmentosum
    Dermatogenetics
    AR
    Dedicated page coming soon

Inheritance pattern

Conditions caused by pathogenic XPA variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous XPA carrier status across ancestry groups?

UK clinical status

XPA appears on multiple NHS Genomic Medicine Service gene panels with green (high evidence) ratings. The gene is included in cancer susceptibility panels for both adult and childhood solid tumours, reflecting its role in DNA repair and cancer predisposition. It also features in the Xeroderma pigmentosum, Trichothiodystrophy or Cockayne syndrome panel (R227), the primary pathway for diagnosing DNA repair disorders presenting with photosensitivity. Additional panel memberships include hereditary neuropathy panels (R78) and monogenic hearing loss (R67), addressing the neurological and sensory complications that can accompany severe DNA repair deficiency.

Frequently asked questions

What is the XPA gene responsible for?

XPA encodes a protein that recognises damaged DNA and coordinates its repair through the nucleotide excision repair pathway. This process removes DNA lesions caused by ultraviolet light, environmental chemicals, and other damaging agents, preventing mutations that could lead to cancer or cell death.

How is xeroderma pigmentosum inherited?

Xeroderma pigmentosum caused by XPA variants follows autosomal recessive inheritance. This means an individual must inherit pathogenic variants from both parents to develop the condition. Carriers with one variant typically have no symptoms but can pass the variant to their children.

Why is XPA-related xeroderma pigmentosum more common in Japanese populations?

Certain XPA variants occur at higher carrier frequencies in Japanese populations due to founder effects, where specific genetic changes became more prevalent in geographically or culturally distinct groups over generations. This population-specific enrichment leads to higher disease incidence in Japan compared to other regions.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .